Ausgabe 3/2021
Inhalt (26 Artikel)
CRISPR-based strategies in infectious disease diagnosis and therapy
Alexandra Binnie, Emanuel Fernandes, Helder Almeida-Lousada, Ramon Andrade de Mello, Pedro Castelo-Branco
Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect
Sofie Schumacher, Jon Salmanton-García, Oliver A. Cornely, Sibylle C. Mellinghoff
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
Hui Xian Jaime Lin, Sanda Cho, Veeraraghavan Meyyur Aravamudan, Hnin Yu Sanda, Raj Palraj, James S. Molton, Indumathi Venkatachalam
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature
Simone Meini, Bruno Viaggi, Carlo Tascini
Correction to: Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature
Simone Meini, Bruno Viaggi, Carlo Tascini
Preoperative synovial fluid culture poorly predicts the pathogen causing periprosthetic joint infection
Philipp Schulz, Constantin E. Dlaska, Carsten Perka, Andrej Trampuz, Nora Renz
Plasma interferon-γ-inducible protein 10 (IP-10) levels correlate with disease severity and paradoxical reactions in extrapulmonary tuberculosis
Isabelle Suárez, Samuel Rohr, Melanie Stecher, Clara Lehmann, Sandra Winter, Norma Jung, Vanessa Priesner, Melanie Berger, Christoph Wyen, Max Augustin, Jakob J. Malin, Julia Fischer, Carola Horn, Florian Neuhann, Michael Püsken, Georg Plum, Gerd Fätkenheuer, Jan Rybniker
Impact of safety warnings for fluoroquinolones on prescribing behaviour. Results of a cohort study with outpatient routine data
Ulrike Georgi, Falko Tesch, Jochen Schmitt, Katja de With
Macrophage migration inhibitory factor − 794 CATT5−8 microsatellite polymorphism and susceptibility of tuberculosis
Felipe Dominguez Machado, Mirela Gehlen, Vitória Schmidt Caron, Gabriel Tassi Mousquer, Graziele Lima Bello, Camila Anton, Rafaela Manzoni Bernardi, Alana Ambos Freitas, Gisela Unis, Elis Regina Dalla Costa, Maria Lucia Rosa Rossetti, Denise Rossato Silva
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes
Rosa Escudero-Sánchez, Angela Valencia-Alijo, Sandra Cuéllar Tovar, Esperanza Merino-de Lucas, Sergio García Fernández, Ángela Gutiérrez-Rojas, Antonio Ramos-Martínez, Miguel Salavert Lletí, Iván Castro Hernández, Livia Giner, Javier Cobo
Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions
André Almeida, Matteo Boattini, Eirini Christaki, Torcato Moreira Marques, Inês Moreira, Lourenço Cruz, Valentina Tosatto, Diogo Antão, Gabriele Bianco, Marco Iannaccone, Cristina Costa, Georgios Tsiolakkis, Elina Khattab, Diamanto Kasapi, Ana Teresa Ferreira, Rossana Cavallo, Rita Corte-Real
Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury
Stéphanie Bieber, Angelina Kraechan, Johannes C. Hellmuth, Maximilian Muenchhoff, Clemens Scherer, Ines Schroeder, Michael Irlbeck, Stefan Kaeaeb, Steffen Massberg, Joerg Hausleiter, Ulrich Grabmaier, Mathias Orban, Ludwig T. Weckbach
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients
L. Schmidt, B.-E. O. Jensen, A. Walker, V. Keitel-Anselmino, V. di Cristanziano, M. Böhm, E. Knops, E. Heger, R. Kaiser, A. de Luca, M. Oette, D. Häussinger, J. Timm, A. Fuchs, N. Lübke
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
Thomas L. Walsh, Derek N. Bremmer, Matthew A. Moffa, Tamara L. Trienski, Carley Buchanan, Kelly Stefano, Catharine Hand, Tricia Taylor, Karen Kasarda, Nathan R. Shively, Nitin Bhanot, Nicholas Cheronis, Briana E. DiSilvio, Christian Y. Cho, Dustin R. Carr
Correction to: Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
Thomas L. Walsh, Derek N. Bremmer, Matthew A. Moffa, Tamara L. Trienski, Carley Buchanan, Kelly Stefano, Catharine Hand, Tricia Taylor, Karen Kasarda, Nathan R. Shively, Nitin Bhanot, Nicholas Cheronis, Briana E. DiSilvio, Christian Y. Cho, Dustin R. Carr
First case of Candida auris isolated from the bloodstream of a Mexican patient with serious gastrointestinal complications from severe endometriosis
J. Jacobo Ayala-Gaytán, Alexandra M. Montoya, Michel F. Martínez-Resendez, Claudia E. Guajardo-Lara, Rogelio de J. Treviño-Rangel, Lorena Salazar-Cavazos, Jorge M. Llaca-Díaz, Gloria M. González
A combined oro-nasopharyngeal swab is more sensitive than mouthwash in detecting SARS-CoV-2 by a high-throughput PCR assay
Wiebke Michel, Jacqueline Färber, Milica Dilas, Hans-Gert Heuft, Ina Tammer, Jannik Baar, Achim J. Kaasch
Shift in bacterial etiology from the CAPNETZ cohort in patients with community-acquired pneumonia: data over more than a decade
D. C. W. Braeken, A. Essig, M. Panning, R. Hoerster, M. Nawrocki, K. Dalhoff, N. Suttorp, T. Welte, M. W. Pletz, M. Witzenrath, G. G. U. Rohde, J. Rupp, M. Dreher, C. Cornelissen, W. Knüppel, D. Stolz, N. Suttorp, W. Bauer, A. Mikolajewska, M. Witzenrath, W. Pankow, S. Gläser, D. Thiemig, M. Prediger, S. Schmager, M. Kolditz, B. Schulte-Hubbert, S. Langner, G. Rohde, C. Bellinghausen, M. Panning, C. Hoffmann, T. Welte, J. Freise, G. Barten, W. Kröner, M. Nawrocki, J. Naim, T. Illig, N. Klopp, M. Pletz, C. Kroegel, B. Schleenvoigt, C. Forstner, A. Moeser, D. Drömann, P. Parschke, K. Franzen, J. Rupp, N. Käding, M. Wouters, K. Walraven, D. Braeken, C. Spinner, A. Zaruchas, D. Heigener, I. Hering, W. Albrich, F. Waldeck, F. Rassouli, S. Baldesberger, S. Stenger, M. Wallner, H. Burgmann, L. Traby
Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia
Valentina Marchese, Verena Crosato, Maurizio Gulletta, Filippo Castelnuovo, Graziella Cristini, Alberto Matteelli, Francesco Castelli
Report on a lactating patient with COVID-19
Xuchun Liu, Li Zhou, Yan Zhu
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
Marianna Meschiari, Iacopo Franconi, Erica Bacca, Vincenzo Bianco, Gabriella Orlando, Gianluca Cuomo, Andrea Bedini, Cristina Mussini
Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values
Lukas Lanser, Rosa Bellmann-Weiler, Karla-Wanda Öttl, Lukas Huber, Andrea Griesmacher, Igor Theurl, Günter Weiss
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
Alexandre Elabbadi, Matthieu Turpin, Grigoris T. Gerotziafas, Marion Teulier, Guillaume Voiriot, Muriel Fartoukh
Characterization and outcomes of acute myocardial injury in COVID-19 intensive care patients
Vincent Labbé, Stephane Ederhy, Nathanael Lapidus, Joe-Elie Salem, Antoine Trinh-Duc, Ariel Cohen, Muriel Fartoukh, Guillaume Voiriot